Quick Answer
Avalo Therapeutics, Inc. reported Shares Outstanding of 18.51 million shares for fiscal year 2025.
Avalo Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 18.51M | +76.8% |
| 2024 | 10.47M | +1206.1% |
| 2023 | 801,746 | +1940.4% |
| 2022 | 39,294 | -99.6% |
| 2021 | 9.40M | -87.5% |
| 2020 | 75.00M | +69.0% |
| 2019 | 44.38M | +8.8% |
| 2018 | 40.80M | +30.5% |
| 2017 | 31.27M | +231.4% |
| 2016 | 9.43M | +9.1% |
| 2015 | 8.65M | +1231.4% |
| 2014 | 649,721 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 17.83M | +84.1% | +64.5% |
| June 30, 2025 | 10.84M | +948.0% | +0.1% |
| March 31, 2025 | 10.83M | +947.0% | +3.4% |
| December 31, 2024 | 10.47M | +1206.1% | +8.2% |
| September 30, 2024 | 9.68M | -95.0% | +836.3% |
| June 30, 2024 | 1.03M | -92.6% | +0.0% |
| March 31, 2024 | 1.03M | -92.2% | +29.0% |
| December 31, 2023 | 801,746 | -91.5% | -99.6% |
- Avalo Therapeutics, Inc. showed an increase of +76.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, Avalo Therapeutics, Inc.’s shares outstanding has grown by 2749.3% (from 649.7 thousand shares to 18.51 million shares).
- The most recent figure is from Avalo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: